Yesterday was a very amazing day as we got the Fast train we never dreamt it would turn out to be such a eventful day.
We were all booked in for BTOG– Mesothelioma UK & British Thoracic Oncology Group (BTOG) – The Essential Update on Wednesday 22nd March 2017, Venue: Welcome Foundation, London
It was pouring with Rain as we walked from St Pancreas to Euston which isn’t to far but in the rain and cold it seemed miles thank goodness we take our stick when we go to London.
I love this meeting as the people who attend are all medical or connected to Mesothelioma in some way. Doctors Nurses as well as Mesothelioma Uk nurses attend with Solicitors and BLF, MSD and other drug companies and so many Doctors that are so Mesothelioma dedicated.
Mesothelioma UK and British Thoracic Oncology Group (BTOG)
Mesothelioma 2017 – The Essential Update
Date: Wednesday 22nd March 2017
Venue: Wellcome Foundation, London – easily accessible from Euston or St Pancreas
Approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 5 category 1 (external) CPD credits (code 109884).
Mesothelioma UK and BTOG are pleased to be collaborating to present Mesothelioma 2017 – The Essential Update. The meeting will be co-chaired by the Mesothelioma UK Chair of Trustees, Professor Michael Peake and BTOG Chair, Dr Sanjay Popat.
The educational meeting will attract over 100 thoracic oncology health care professionals from the multi-disciplinary team
09:00 Registration and Refreshments – Williams Lounge Meeting – Henry Wellcome Auditorium Chairs: Michael Peake and Liz Darlison 09:30 Open and Welcome Michael Peake 09:35 Mesothelioma UK’s Strategy for Making Mesothelioma Matter Liz Darlison and an Update on the Mesothelioma Coalition 10:00 National Mesothelioma Audit Susan Harden 10:15 BTS Mesothelioma Guidelines Ian Woolhouse 10:30 Panel 10:45
Diagnosis, Staging and Symptom Control in 2017 11:15 Approaches to the Optimal Diagnosis of Mesothelioma Nick Maskell 11:30 Mesothelioma Staging Classification John Edwards 11:45 Symptom Control in Mesothelioma Andrew Wilcock 12:00 Does the Specialist Mesothelioma MDT Add Value? Anna Bibby 12:15 National Peritoneal Mesothelioma MDT Emily Arbuthnot-Smith and Akash Mehta 12:30 Panel
Supporting Research in 2017 Chairs: Sanjay Popat and Peter Szlosarek 13:45 Mesobank Robert Rintoul 14:00 The Importance of Mesothelioma Genetics Bill Cookson 14:20 Basic Science Research Funding and Grants Ian Jarrold 14:30 Panel
The Clinical Trials Portfolio in 2017 – Criteria and How to Access 15:00 Chemotherapy/Immunotherapy Sanjay Popat 15:20 Radiotherapy Noelle O’Rourke 15:35 Surgical Eric Lim 15:50 Panel 16:15 Close
Emily Arbuthnot-Smith, Peritoneal Malignancy Service Manager, Hampshire Hospitals NHSFT
Dr Anna Bibby, NIHR Doctoral Research Fellow, School of Clinical Sciences, University of Bristol
Professor William Cookson (Bill), Professor of Genomic Medicine, Imperial College London
Liz Darlison, Mesothelioma UK Director of Services and Consultant Nurse, University Hospitals of Leicester NHS Trust
Mr John Edwards, Consultant Thoracic Surgeon, Northern General Hospital, Sheffield and BTOG Chair of Trustees
Dr Susan Harden, Consultant Clinical Oncologist, Cambridge University Hospitals
Ian Jarrold, Head of Research, British Lung Foundation
Mr Eric Lim, Consultant Thoracic Surgeon, Royal Brompton & Harefield NHS Foundation Trust
Professor Nick Maskell, Professor of Respiratory Medicine, University of Bristol
Dr Akash Mehta, Clinical Fellow, Hampshire Hospitals NHSFT
Professor Michael Peake, Honorary Consultant and Professor of Respiratory Medicine, University of Leicester and Clinical Lead for Early Diagnosis, National Cancer Registration and Analysis Service (NCRAS), Public Health England and Mesothelioma UK Chair of Trustees
Dr Sanjay Popat, Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London and BTOG Chair
Dr Noelle O’Rourke, Consultant Clinical Oncology, Beatson Oncology Centre, Glasgow
Dr Robert Rintoul, Consultant Respiratory Physician, Papworth Hospital NHS Foundation Trust
Dr Peter Szlosarek, Clinical Senior Lecturer and Consultant in Medical Oncology at the Barts Cancer Institute (QMUL) and St. Bartholomew’s Hospital
Dr Andrew Wilcock, Clinical Reader in Palliative Medicine and Medical Oncology, University of Nottingham
Dr Ian Woolhouse, Consultant Respiratory Physician, University Hospitals Birmingham